
Opinion|Videos|August 20, 2024
Key Takeaways for Biosimilar Utilization
The panelists provide their closing thoughts, highlighting key considerations around biosimilar.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Thanks to all of you for this rich and informative discussion. Before we conclude I’d like to get final thoughts from each of you…
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
3
Advancing Biomarker Testing Across GU, Lung, and Myeloma Care
4
Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma
5



























































